Baseline asthma burden, comorbidities, and biomarkers in omalizumab-treated patients in PROSPERO Response

Greenberger Paul A.; Oppenheimer John J.

首页> 外文期刊>Annals of allergy, asthma, and immunology >Baseline asthma burden, comorbidities, and biomarkers in omalizumab-treated patients in PROSPERO Response

【24h】

Baseline asthma burden, comorbidities, and biomarkers in omalizumab-treated patients in PROSPERO Response

机译：基准哮喘负担，莫拉姆采购治疗患者在Prospero反应中的基础哮喘负担，和生物标志物

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《Annals of allergy, asthma, and immunology》 |2018年第5期|共2页
作者
Greenberger Paul A.; Oppenheimer John J.;
展开▼
作者单位

Northwestern Univ Chicago IL 60611 USA;

UMDNJ NJ Med Sch Cedar Knolls NJ USA;

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类医学免疫学;
关键词

相似文献

外文文献
中文文献
专利

1. Baseline asthma burden, comorbidities, and biomarkers in omalizumab-treated patients in PROSPERO Response [J] . Greenberger Paul A., Oppenheimer John J. Annals of allergy, asthma, and immunology . 2018,第5期

机译：基准哮喘负担，莫拉姆采购治疗患者在Prospero反应中的基础哮喘负担，和生物标志物
2. Baseline asthma burden, comorbidities, and biomarkers in omalizumab-treated patients in PROSPERO [J] . Bradley E. Chipps, Robert S. Zeiger, Allan T. Luskin, Annals of allergy, asthma, and immunology . 2017,第6期

机译：基线哮喘负担，可融化的哮喘治疗欧洲治疗患者的哮喘负担
3. Baseline asthma burden, comorbidities, and biomarkers in omalizumab-treated patients in PROSPERO [J] . John J. Oppenheimer, Paul A. Greenberger Annals of allergy, asthma, and immunology . 2017,第6期

机译：基线哮喘负担，可融化的哮喘治疗欧洲治疗患者的哮喘负担
4. Machine Learning-Based A Priori Chemotherapy Response Prediction in Breast Cancer Patients using Textural CT Biomarkers* [C] . Hadi Moghadas-Dastjerdi, Hira R. Sha-E-Tallat, Lakshmanan Sannachi, Annual International Conference of the IEEE Engineering in Medicine and Biology Society . 2020

机译：基于纹理学习生物标志物的乳腺癌患者基于机器学习的先验化学疗法反应预测*
5. The association between baseline fructose consumption and baseline biomarkers of inflammation in a randomized controlled feeding trial. [D] . Luo, Ke. 2015

机译：在一项随机对照喂养试验中，基线果糖消耗与炎症基线生物标志物之间的关联。
6. The Prognostic Role of Baseline Metabolic Tumor Burden and Systemic Inflammation Biomarkers in Metastatic Castration-Resistant Prostate Cancer Patients Treated with Radium-223: A Proof of Concept Study [O] . Matteo Bauckneht, Sara Elena Rebuzzi, Alessio Signori, 2020

机译：基线代谢肿瘤负荷和全身炎症生物标志物在镭致阉割前列腺癌患者中的预后作用 - 223治疗 - 概念研究证明
7. Biomarkers Associated with Response in Patients Initiating Omalizumab: Baseline Levels Among Patients in the Prospective Observational Study to Evaluate Predictors of Clinical Effectiveness in Response to Omalizumab (PROSPERO) Study [O] . Bradley E. Chipps, William W. Busse, Allan T. Luskin, 2016

机译：与omalizumab的患者的反应相关的生物标志物：前瞻性观察研究中患者的基线水平，以评估奥拉姆利亚布（Prospero）研究的临床效果预测因子

Baseline asthma burden, comorbidities, and biomarkers in omalizumab-treated patients in PROSPERO Response

著录项

相似文献

相关主题

期刊订阅